Hatri Pharma Private Limited
About Hatri Pharma Private Limited
Data last updated:
Hatri Pharma Private Limited is a private limited company based in Tirumalagiri, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 July 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TS2010PTC205106. Its GSTIN is 37AACCH4672C1ZQ (Andhra Pradesh).
The company has an authorised share capital of ₹27 Cr and a paid-up capital of ₹23.73 Cr. It is led by directors including Sumalatha Ambarapu and Rebala Rupakala.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Tirumalagiri, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹71.68 Lakh, a decline of 93% compared to the previous year.
As per MCA filings, the company has open charges of ₹13.5 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No.16 2nd Floor, Durga Shakti Peetam Prashanthi Nagar, Tirumalagiri, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
CIN History of Hatri Pharma Private Limited
Hatri Pharma has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24232TS2010PTC205106, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TS2010PTC205106 | Current |
| U24232TG2010PTC069596 | Previous |
| U24232AP2010PTC116314 | Previous |
| U24232AP2010PTC069596 | Previous |
Business Activity of Hatri Pharma Private Limited
The main business activity of Hatri Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Board of Directors of Hatri Pharma Private Limited
Hatri Pharma has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumalatha Ambarapu | Director | 09 Aug 2023 | 3 Years 1 Months | Current |
| Rebala Rupakala | Director | 30 Oct 2017 | 8 Years 11 Months | Current |
| Mohan Reddy Enaganuri | Director | 21 Jul 2010 | 16 Years 2 Months | Current |
Financials of Hatri Pharma Private Limited FY 2025 filings available
Hatri Pharma Private Limited reported revenue of ₹71.68 Lakh (down 93.00% YoY) for FY 2025.
Financial Statement Summary of Hatri Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹71.68 Lakh | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Hatri Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Hatri Pharma are in the company report.
Ten-year financial statements
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Hatri Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Sep 2020 | Others | ₹13.5 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Hatri Pharma Private Limited
Employment history and EPFO contributions of people linked to Hatri Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Hatri Pharma Private Limited
Hatri Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AACCH4672C1ZQ | Andhra Pradesh | Active | 22 Jun 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Hatri Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Hatri Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Hatri Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Hatri Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Hatri Pharma Private Limited
Frequently Asked Questions about Hatri Pharma Private Limited
Hatri Pharma is an active private limited company based in Tirumalagiri, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 July 2010 (16+ years old) and is registered under CIN U24232TS2010PTC205106.
Hatri Pharma reported revenue of ₹71.68 Lakh for FY 2025 (down 93.00% YoY).
Hatri Pharma has 3 current directors:
- Sumalatha Ambarapu - Director
- Rebala Rupakala - Director
- Mohan Reddy Enaganuri - Director
The GSTIN of Hatri Pharma is 37AACCH4672C1ZQ, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Hatri Pharma is U24232TS2010PTC205106. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hatri Pharma was incorporated on 21 July 2010, making it 16+ years old. It is registered with the Registrar of Companies, Hyderabad.
The registered office of Hatri Pharma is at Plot No.16 2nd Floor, Durga Shakti Peetam Prashanthi Nagar, Tirumalagiri, Telangana, India – 500072.
Hatri Pharma has an authorised share capital of ₹27 Cr and a paid-up capital of ₹23.73 Cr.
Hatri Pharma operates in the pharma industry, in the drug formulation and development segment.